UTI AMC schedules analyst and institutional investor meet
UTI Asset Management Company Limited announced an analyst and institutional investor meeting scheduled for June 4, 2026, at its Corporate Office in BKC, Mumbai. The in-person session, arranged by Nomura for SPARX Asset Management, will not involve sharing unpublished price sensitive information.

*this image is generated using AI for illustrative purposes only.
UTI Asset Management Company Limited has scheduled an analyst and institutional investor meeting with its senior management for June 4, 2026. The meeting is set to take place at 1600 hrs IST at the Corporate Office in BKC, Mumbai. The session is arranged by Nomura Financial Advisory & Securities (India) Private Limited for SPARX Asset Management.
The disclosure was made to the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 30 read with Schedule III Part A Para A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Arvind Patkar, Company Secretary and Compliance Officer.
The meeting will be conducted in person and classified as a group meet. The company stated that no unpublished price sensitive information (UPSI) will be shared during the discussion. The schedule of the meeting is subject to change.
| Date & Time | Name | Mode of the Meeting | Place |
|---|---|---|---|
| 4 June, 2026 at 1600 hrs IST | SPARX Asset Management meeting arranged by Nomura Financial Advisory & Securities (India) Private Limited | In person | Corporate Office, BKC, Mumbai |
Historical Stock Returns for UTI AMC
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.07% | +1.56% | +2.90% | -17.62% | -20.70% | +27.58% |
What strategic outcomes does UTI AMC anticipate from this engagement with SPARX Asset Management?
Could this meeting signal potential future collaborations or cross-border investment opportunities between the firms?
How might the involvement of Nomura as an intermediary influence UTI AMC's institutional investor outreach strategy?

































